Latest News & Features
Biotech
Judges dismissed an appeal from MSN Laboratories, which was hoping to show that several patents covering Cabometyx were invalid and would not be infringed by its generic product. 1 September 2026
Careers
Two patent litigators have jumped ship from a boutique to join Pinsent Masons' Düsseldorf office, as the firm aims to strengthen its UPC firepower. 1 September 2026
Biotech
Efforts to shut down an eight-patent dispute over cancer-detection technology have run into a hurdle in a Delaware federal court. 31 August 2026
Europe
This year’s tables provide a guide to the best of the UK market for legal advice on the protection, enforcement and exploitation of patents. 28 August 2026
Pharma
Turkish regulators are investigating the drugmaker over its efforts to protect its drug from generic rivals—conduct that may sound familiar to European competition watchers. 27 August 2026
Regulation & Industry
Dozens of new and revised guidances could make it faster and less costly to bring generics to market, as the US ramps up pressure on drug prices. 27 August 2026
Biotech
As China-origin biotech assets flood the market, licensing deals are booming. Yet, the real strategic battle isn't just about the science—it’s about who controls the underlying IP, says Paul Calvo of Sterne Kessler 27 August 2026
Careers
The new practice head has represented life sciences clients in numerous high-profile disputes, and will be an “invaluable resource for our clients”, according to the firm. 26 August 2026
Regulation & Industry
While promising science draws in buyers, intellectual property determines the price, terms, and viability of an agreement. LSIPR digs into what investors are looking for—and the biggest turn-offs that destroy a deal. 25 August 2026
Regulation & Industry
Labour MP for Stockton North takes up a new role as Minister for Science, Innovation and Investment within Andy Burnham’s government. 24 August 2026